AgentTrading
How it works
AI stock analysis AI stock research Backtesting software Strategy builder Fundamental analysis Options backtesting Risk analysis Historical data Portfolio backtesting Stock analysis tools Best AI trading software AI investing tools AI stock trading AI trading agent ETF backtesting Dividend backtesting Covered call backtest Momentum backtest Moving average crossover RSI backtest TradingView backtesting Automated trading platforms Historical options data Stock backtesting Sharpe ratio calculator AI swing trading AI day trading TrendSpider pricing AI equity research Trade Ideas pricing Finviz pricing Investment research software Koyfin pricing Backtesting for advisors Non-professional subscriber Screener with backtesting QuantConnect pricing Option Alpha pricing YCharts pricing Bloomberg alternative for advisors Bloomberg Anywhere cost FactSet cost Morningstar Direct cost LSEG Workspace pricing Value Line subscription cost Portfolio Visualizer cost Stock Rover pricing GuruFocus pricing Seeking Alpha pricing Zacks pricing Motley Fool pricing Benzinga Pro pricing Danelfin pricing Tickeron pricing TC2000 pricing MetaStock pricing Sierra Chart pricing NinjaTrader pricing Backtesting software pricing comparison StockCharts pricing Tradervue pricing WealthLab pricing StrategyQuant pricing Portfolio123 pricing OptionStrat pricing Cheddar Flow pricing BlackBoxStocks pricing ORATS pricing TraderSync pricing Tradytics pricing Unusual Whales pricing Quiver Quantitative pricing Composer pricing
Pricing Blog FAQ Log in

ORATS Review for Options Traders Weighing the $99 Plan

November 18, 2026 · AgentTrading

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Type for a real run
01 THESIS · AS A TESTABLE RULE

02 EVIDENCE · FUNDAMENTALS

03 BACKTEST · GROWTH OF $10,000
Strategy Buy & hold

04 RISK · IN PLAIN ENGLISH

05 VERDICT · HISTORICAL, NOT PREDICTIVE

Sample scenarios, not a live backtest of what you typed. Past performance does not guarantee future results. Educational analysis only, not financial advice.

ORATS is one of the best options backtesters a retail trader can buy, and at $99 a month for Trading Tools it is fairly priced for one kind of buyer: an options trader who sells premium or trades spreads and wants to see how a structure behaved on real quoted chains since 2007. It is the wrong purchase if your idea is a stock or ETF rule, if you need the data in code without paying a second subscription, or if you trade for clients on the individual price.

We read the ORATS Trading Tools page, the Data API page and the end-of-day data page on November 18, 2026 in a rendered browser. Every price and quote below comes from those pages, and anything we calculated is marked as our arithmetic. The full plan table, including every API tier and add-on, is on our ORATS pricing page. This review is about the decision: who should pay, for what, and what ORATS will not answer.

Is ORATS worth it

For a trader who sells puts, writes calls or runs iron condors on liquid names, yes. The backtester runs on end-of-day option chains back to 2007 for about 6,000 symbols, which takes a structure through 2008, the 2018 volatility spike, 2020 and 2022 on prices that were actually quoted. ORATS also lets you browse more than 300 million precomputed backtests without spending your allowance, so a lot of questions are answered before you build anything.

For everyone else it is a harder sell. A long-term investor testing a moving average exit on an index fund does not need option chains at all. A trader who wants the numbers in Python pays for the Data API on top, from $199 a month. And anyone running tests for a fund, for clients or on a shared login is a professional user at $199 per user a month, which doubles the bill before any data.

What ORATS costs in year one for four kinds of buyer

The pricing page lists products, not situations. Here is what the same vendor costs in the first year for four buyers we see often, using only the prices on the ORATS pages. Every total is our arithmetic.

BuyerWhat they buyMonthlyYear one
A retail premium seller who works in the browserTrading Tools, individual$99$1,188
The same trader who also pulls chains into PythonTrading Tools plus the Delayed Data API$298$3,576
A researcher who only needs the historyNear end-of-day files 2007 to today, plus new daily files$599 once, then $99$1,787 (or $599 if you skip the new files)
A three-person advisory deskTrading Tools, professional, 3 users$597$7,164

Two things stand out. The researcher who buys the history files once pays about half of what the browser trader pays in a year and keeps the files, but gets no backtester with them. And the advisory desk pays six times what a solo trader pays for the same screens, purely because of the license type. If you sit anywhere near the line between individual and professional, settle it before checkout, not after. For a small advisory desk the research seats are rarely the biggest drain on adviser hours anyway; the discovery call with each new client usually is, and that intake step is what consultations.ai automates.

What you get for $99 a month

Trading Tools is a single subscription with everything in it: the options backtester, an intraday backtester, the option and stock scanners, trade ideas, a strategy optimizer, ticker analysis, a trade builder, order routing to Interactive Brokers, TradeStation and Tradier, an AI agent called Otto, and real-time data once you sign the exchange agreements. Until you sign them, quotes run 15 minutes behind.

The backtester is the reason to buy. ORATS lists 45 strategies, and each result carries a return graph, 37 performance metrics, a monthly return table and a downloadable trade log. The intraday mode tests 0DTE and short-dated trades on 1-minute data back to October 2020. Custom tests are capped at 2,000 a month, which is about 95 per trading day (our arithmetic) and plenty for almost anyone.

A worked example of the 2,000-test allowance

Say you sell monthly puts and want to find the delta and exit that held up best. You test 5 deltas (10 to 30 in steps of 5), 4 days to expiration (30, 45, 60, 90) and 3 exits (50% profit, 21 days left, hold to expiry). That is 60 combinations per ticker. Across 20 tickers it is 1,200 custom tests, which fits in one month with 800 left over. Push it to 35 tickers and you hit 2,100 and run out. In practice you would check the precomputed library first, which does not count against the cap, and only build the combinations it lacks.

What the ORATS end-of-day price actually is

ORATS states that its strike quotes are "gathered 14 minutes before the close to avoid wide spreads" and cleaned with its own Smoothed Market Values system. That is a sensible choice, because option spreads widen into the bell and a 4:00 pm quote is often a price nobody could trade. It also means a backtest that assumes you filled at the close is really assuming you filled at about 3:46 pm at a smoothed mid. Read every result with that in mind, especially on wide, illiquid strikes where the smoothed value and a real fill can sit far apart.

The second detail is on the Data API page: ORATS does not supply stock prices. The underlying values in its data are derived from option prices through put-call parity and, in its own words, "are for internal use only". If your test needs real adjusted stock prices, you need a second source.

Does ORATS have a free trial

No. ORATS offers no free trial on Trading Tools or the Data API. Trading Tools refunds the full charge automatically if you cancel within 24 hours of signing up, so plan to run every backtest you care about on day one. Cancelling is one click in the Subscriptions tab. Students get up to 50% off, without live data and broker connections.

Some older reviews still describe a paid 14-day trial. The current Trading Tools FAQ says plainly that there is no free trial and that the 24-hour refund replaces it, so trust the vendor page over anything written in an earlier year.

Is the ORATS API included

No, and ORATS calls this "the most common mix-up" in its own FAQ. Trading Tools is the dashboard you click. The Data API is a separate plan: Delayed $199 a month with 20,000 requests, Live $299 with 100,000, Live Intraday $599 with 1,000,000 and one-minute chains, and All-In $899 with every endpoint. Four Tools APIs, the Option Scanner, Backtest Finder, Intraday Backtester and Time and Sales, add $99 or $299 each. All-In is shown against a struck-through $1,395, which is exactly Live Intraday plus all four add-ons, so the $496 saving is real.

The API prices have moved. When we read the same page on August 31, 2026 the plans were $99, $199 and $399 a month, and our historical options data comparison now carries the November figures next to ThetaData, Massive and the outright file sellers.

ORATS compared with the tools buyers weigh it against

ToolPriceBest forWhere it falls short
ORATS Trading Tools$99 a month, $199 professionalBacktesting options structures on real chains since 2007No trial, API billed separately, no real stock prices
OptionStrat$39.99 or $99.99 a monthBuilding positions on live greeks and watching flowNot a historical backtester, no refunds after the trial
Option Alpha$149 a month, $99 billed annually, or $0 through partner brokersAutomating short-dated options botsBacktests cover at most three years on seven symbols
AgentTrading Analyst$99 a month, $49.50 billed yearlyJudging a covered call, cash secured put or stock rule against buy and hold over 20+ yearsPremiums are modelled, not quoted, and it places no orders

Plan details for the middle two are on OptionStrat pricing and Option Alpha pricing. If covered calls are the whole question, our roundup of the best options backtesting software for covered call sellers compares the cheaper routes, including tastytrade's free Lookback.

Where ORATS beats us and where it does not

ORATS wins on real option prices. Our options backtesting bench does not hold a historical option chain. It prices each contract with Black and Scholes on the volatility the stock actually realised in the 60 sessions before the trade, and the result says so in its first assumption. Implied volatility has historically tended to sit above realised volatility, so a premium priced that way usually understates what a call or put seller really collected. If the edge in your idea is a few tenths of a percent of premium a month, that gap matters and ORATS is the right tool.

Where we fit is earlier in the decision. You describe the structure in a sentence, such as "write a 30-delta call on SPY every month", confirm the rule card, and get the equity curve, the worst drawdown and a plain verdict against simply holding the shares, on 20+ years of split- and dividend-adjusted daily data. That answers the first question, whether call writing on that name gave up more upside than it earned, before you pay for quoted chains. The covered call backtest page shows the output, and the same bench handles stock and ETF rules that ORATS was never built for.

If you trade through TradeStation, its own help page limits option history to contracts not yet expired, which is why many TradeStation users end up pricing ORATS. The details are in TradeStation option backtest cost and limits.

The verdict

Buy ORATS Trading Tools if you trade options structures and want real quoted history since 2007, and plan to spend your first 24 hours running the tests that matter, because that window is the only trial. Budget the Data API separately if you code. Use the professional price if anyone else touches the account. If your idea is a stock rule or a first look at a covered call, test it on our bench first and only pay for chain-level data if the modelled result is close enough to need it.

Prices and terms are as read on the ORATS Trading Tools page on November 18, 2026. Options carry real risk of loss, and the OCC options disclosure document is worth reading before any of these tools. This is educational analysis, not advice, and past results do not guarantee future ones.

Put it on the bench

Ideas are cheap. Verdicts take a bench.

AgentTrading restates your idea as a testable rule, backtests it on 20+ years of adjusted daily data, and explains the risks in plain English. Honest verdicts, even when the idea loses.

Get started

Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.

Get started